Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, et al
The commentary is not meant to diagnose, treat or replace conventional treatment, and has not been approved or reviewed by the FDA, Health Canada, BMS, European Union Health Commission, South and Central American regulation agencies etc.
What we can say: GLP-1s and GLP-1/GIP agonists clearly reduce body weight, fat mass, visceral fat, and ectopic fat
We still retain that mission because we believe that proper hydration and nutrition can make a massive difference to peoples health and quality of life
Maintained glutathione levels in both cytosol and mitochondria, preventing redox imbalance caused by TRX2 deficiency
doi: 10.17925/EE.2022.18.1.35 39 WangL